Variant report
Variant | esv3333263 |
---|---|
Chromosome Location | chr9:27090566-27091085 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10967707 | chr9:27090623-27090624 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs558041946 | chr9:27090634-27090635 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576016679 | chr9:27090667-27090668 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543844746 | chr9:27090681-27090682 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562016271 | chr9:27090688-27090689 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs574110877 | chr9:27090729-27090730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541181273 | chr9:27090750-27090751 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113091152 | chr9:27090755-27090756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549435199 | chr9:27090777-27090778 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs138129988 | chr9:27090789-27090790 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544123818 | chr9:27090814-27090815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs112290999 | chr9:27090830-27090831 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs370776034 | chr9:27090853-27090854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs527485108 | chr9:27090855-27090856 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552459274 | chr9:27090856-27090857 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs564420095 | chr9:27090919-27090920 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs555271352 | chr9:27090953-27090954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs182846258 | chr9:27090968-27090969 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs549783149 | chr9:27090996-27090997 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567979978 | chr9:27091035-27091036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21858162 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
polycythaemia | 22829968 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21364760 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
Epilepsy | 22083797 | CNVD |
Cancer | 22183965 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:27024800-27094800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr9:27086600-27091000 | Enhancers | Muscle Satellite Cultured Cells | -- |
3 | chr9:27086800-27090600 | Enhancers | HSMM | muscle |
4 | chr9:27087400-27092200 | Enhancers | Osteobl | bone |
5 | chr9:27087800-27090800 | Enhancers | NHLF | lung |
6 | chr9:27088800-27090600 | Enhancers | HSMMtube | muscle |
7 | chr9:27088800-27090800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr9:27089200-27090600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
9 | chr9:27089400-27091200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr9:27089400-27092200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr9:27089600-27094000 | Weak transcription | Fetal Kidney | kidney |
12 | chr9:27090200-27094000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr9:27090200-27094000 | Weak transcription | NH-A | brain |
14 | chr9:27090600-27091600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
15 | chr9:27090600-27093800 | Weak transcription | HSMMtube | muscle |
16 | chr9:27090600-27094000 | Weak transcription | HSMM | muscle |
17 | chr9:27090800-27094000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
18 | chr9:27090800-27094600 | Weak transcription | NHLF | lung |
19 | chr9:27091000-27093800 | Weak transcription | Muscle Satellite Cultured Cells | -- |